Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Claus Thestrup portrait

Claus Thestrup

CEO, Sweden

Coverage

BoMillFlerieNeoDynamicsPharma Equity GroupAscelia PharmaBioPortoCurasightExpreS2ion Biotech HoldingQlife Holding

Latest content

ShowingAll content types

Ascelia Pharma - Recording of Q1-2025 presentation

Analyst Comment 2025-05-20 08:02 by Claus Thestrup
Ascelia Pharma

Ascelia Pharma: Q1 report with positive Outcome of Orviglance FDA Meeting

Analyst Comment 2025-05-16 09:11 by Claus Thestrup
Ascelia Pharma

Gubra: Trading statement Q1-2025

Analyst Comment 2025-05-09 08:20 by Claus Thestrup
Gubra

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Curasight (One-pager): Funding of pipeline

Research 2025-05-07 08:02 by Philip Coombes, Claus Thestrup
Curasight

Bioporto (One-pager): Capital secured via private placement

Research 2025-04-15 16:36 by Claus Thestrup, Philip Coombes
BioPorto

ExpreS2ion Biotech: Signs Letter of Intent with WuXi Vaccines

Analyst Comment 2025-04-15 14:33 by Michael Friis, Claus Thestrup
ExpreS2ion Biotech Holding

Ascelia Pharma - Podcast with Deputy CEO Julie Waras Brogren and CSO Andreas Norlin

Video 2025-04-04 11:04 by Claus Thestrup
Ascelia Pharma

Ascelia Pharma: Subscription price for warrant TO1 and terms for exercising

Analyst Comment 2025-04-01 08:22 by Claus Thestrup
Ascelia Pharma

Pharma Equity Group (One-pager): Proof-of-Concept year 2025

Research 2025-03-31 16:16 by Philip Coombes, Claus Thestrup
Pharma Equity Group

Gubra: Understanding valuation (PoS) post Abbvie deal

Video 2025-03-26 08:55 by Philip Coombes, Claus Thestrup
Gubra
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.